+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID06482671

A Phase 3 Study Comparing Rikkunshito Herbal Medicine to Placebo for Treatment of Functional Dyspepsia with Postprandial Distress Syndrome in Adults

Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2025-07-23

100

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying functional dyspepsia FD, a condition that causes chronic or recurrent upper stomach symptoms like pain, burning, fullness after meals, and early feeling of fullness. This study focuses on a specific FD type called postprandial distress syndrome PDS, which has symptoms that are often unexplained after standard tests. The study will evaluate the herbal medicine Rikkunshito TJ-43 compared to a placebo to see if it helps with these symptoms and affects inflammation in the small intestines lining. Participants will receive either Rikkunshito or a placebo three times daily by mouth. Each dose is 2.5 grams dissolved in about 30 ml of lukewarm water, taken about 30 minutes before meals. The study lasts 8 weeks, during which the effects of the medicine on symptoms, intestinal lining health, immune activity, gut bacteria, gastric emptying, and quality of life will be measured. During the trial, participants will be monitored for symptom improvement and changes in intestinal inflammation and microbiome. Researchers will assess symptoms, quality of life, psychological distress, and gastric emptying rates. The main outcome is the percentage of participants responding to Rikkunshito compared to placebo after 8 weeks. The study is randomized and triple-blinded, ensuring careful monitoring and comparison throughout the treatment period.

CONDITIONS

Brief Title

Primary Care dySpEpsia rikkuNshiTo

Research Team

J

Jan Tack, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here